◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 2407

Gaush Meditech Ltd (2407) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-08-11

Gaush Meditech Ltd (2407) operates in the Medical Devices industry and is headquartered in Beijing, China with about 893 employees. Its market capitalization is roughly CNY 710 million. In the fiscal year ended 2025-12-31, 2407 reported CNY 1.4B in revenue and CNY 96M in net income.

Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers.

Interactive charts & full statements →

2407 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 1.4BCNY 1.4BCNY 1.4BCNY 1.3B
Gross ProfitCNY 633MCNY 663MCNY 692MCNY 625M
Operating Income (EBIT)CNY 145MCNY 226MCNY 279MCNY 265M
Net IncomeCNY 96MCNY 92MCNY 174M(CNY 350M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2407 Free Cash Flow History

2407 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 2.6BCNY 2.6BCNY 2.8BCNY 2.7B
Total LiabilitiesCNY 927MCNY 978MCNY 1.1BCNY 1.2B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2407 viewer.

Other Companies in Medical Devices

← 2405All “0-9” companies2408 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.